Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discordance between mean glucose and time in range in relation to HbA1c in individuals with type 1 diabetes: results from the GOLD and SILVER trials.
Sterner Isaksson S, Imberg H, Hirsch IB, Schwarcz E, Hellman J, Wijkman M, Bolinder J, Nyström T, Holmer H, Hallström S, Ólafsdóttir AF, Pekkari S, Polonsky W, Lind M. Sterner Isaksson S, et al. Among authors: bolinder j. Diabetologia. 2024 Aug;67(8):1517-1526. doi: 10.1007/s00125-024-06151-2. Epub 2024 Apr 26. Diabetologia. 2024. PMID: 38668761 Free PMC article. Clinical Trial.
HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden.
Bakhtadze E, Borg H, Stenström G, Fernlund P, Arnqvist HJ, Ekbom-Schnell A, Bolinder J, Eriksson JW, Gudbjörnsdottir S, Nyström L, Groop LC, Sundkvist G. Bakhtadze E, et al. Among authors: bolinder j. Diabetologia. 2006 Aug;49(8):1785-94. doi: 10.1007/s00125-006-0293-5. Epub 2006 May 31. Diabetologia. 2006. PMID: 16783473 Free article.
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study).
Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Pehrsson NG, Moström P. Lind M, et al. Among authors: bolinder j. J Diabetes Sci Technol. 2016 May 3;10(3):754-61. doi: 10.1177/1932296816642578. Print 2016 May. J Diabetes Sci Technol. 2016. PMID: 27081191 Free PMC article. Clinical Trial.
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Ólafsdóttir AF, Frid A, Wedel H, Ahlén E, Nyström T, Hellman J. Lind M, et al. Among authors: bolinder j. JAMA. 2017 Jan 24;317(4):379-387. doi: 10.1001/jama.2016.19976. JAMA. 2017. PMID: 28118454 Clinical Trial.
Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
Oskarsson P, Antuna R, Geelhoed-Duijvestijn P, Krӧger J, Weitgasser R, Bolinder J. Oskarsson P, et al. Among authors: bolinder j. Diabetologia. 2018 Mar;61(3):539-550. doi: 10.1007/s00125-017-4527-5. Epub 2017 Dec 23. Diabetologia. 2018. PMID: 29273897 Free PMC article. Clinical Trial.
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).
Ólafsdóttir AF, Polonsky W, Bolinder J, Hirsch IB, Dahlqvist S, Wedel H, Nyström T, Wijkman M, Schwarcz E, Hellman J, Heise T, Lind M. Ólafsdóttir AF, et al. Among authors: bolinder j. Diabetes Technol Ther. 2018 Apr;20(4):274-284. doi: 10.1089/dia.2017.0363. Epub 2018 Apr 2. Diabetes Technol Ther. 2018. PMID: 29608107 Free PMC article. Clinical Trial.
199 results